{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-004080","form_type":"8-K","ticker":"NTLA","cik":"0001652130","company_name":"Intellia Therapeutics, Inc.","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.316080+00:00","generated_at":"2026-05-28T05:08:27.887913+00:00","sec_items":["2.02","2.05","5.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Intellia restructures to focus on NTLA-2002 and nex-z, cuts 27% headcount, extends cash runway to H1 2027","bullets":["Preliminary cash, cash equivalents and investments of $862M as of Dec 31, 2024.","Strategic restructuring: prioritize NTLA-2002 and nex-z; discontinue NTLA-3001 and select research programs.","Net workforce reduction of approximately 27% in 2025; estimated $8M restructuring charges in Q1 2025.","Cash runway extended to first half of 2027.","CSO Laura Sepp-Lorenzino to retire Dec 31, 2025; Birgit Schultes promoted to EVP and CSO effective Jan 13, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-004080","json":"https://secwatch.observer/filing/0001193125-25-004080.json","markdown":"https://secwatch.observer/filing/0001193125-25-004080.md","text":"https://secwatch.observer/filing/0001193125-25-004080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652130/000119312525004080/0001193125-25-004080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652130/000119312525004080/d906527d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T05:08:27.887913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3b92a6dbf7","claim":"Laura Sepp-Lorenzino departed as Executive Vice President and Chief Scientific Officer at Intellia Therapeutics, Inc..","evidence_excerpt":"Laura Sepp-Lorenzino, Ph.D., the Company’s Executive Vice President and Chief Scientific Officer (“CSO”), will retire from the Company and that her anticipated retirement date is December 31, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312525004080/0001193125-25-004080-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will retire"},{"label":"Role","value":"Executive Vice President and Chief Scientific Officer"}],"fact_type":"executive_change"},{"claim_id":"976c73992e","claim":"Laura Sepp-Lorenzino changed role as Special Advisor to the Chief Executive Officer at Intellia Therapeutics, Inc..","evidence_excerpt":"effective January 13, 2025, Dr. Sepp-Lorenzino will become Special Advisor to the Chief Executive Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312525004080/0001193125-25-004080-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will become"},{"label":"Role","value":"Special Advisor to the Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"c490d927c3","claim":"Birgit Schultes was appointed as Executive Vice President and Chief Scientific Officer at Intellia Therapeutics, Inc..","evidence_excerpt":"Birgit Schultes, Ph.D. will become the Company’s Executive Vice President and CSO, effective as of January 13, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312525004080/0001193125-25-004080-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will become"},{"label":"Role","value":"Executive Vice President and Chief Scientific Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}